Our findings align with those of previous research, as we observed a downregulation of Th-17 cells and inflammatory factors following the administration of AMM/I, suggesting the potential suppression of arthritis through the action of IGF-1 derived from AMM/I. This evidence concerns the gene IGF1 and arthritic joint disease.